Ebola Virus DiseaseSymptoms, Doctors, Treatments, Advances & More
Learn About Ebola Virus Disease
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Emory University Hospital Midtown
Colleen Kraft is an Infectious Disease provider practicing medicine in Atlanta, Georgia. She has been practicing medicine for over 24 years. Dr. Kraft is rated as an Elite provider by MediFind in the treatment of Ebola Virus Disease. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Ebola Virus Disease, Viral Hemorrhagic Fever, Sepsis, Severe Acute Respiratory Syndrome (SARS), and Cataract Removal. Dr. Kraft is board certified in American Board Of Pathology, 2011.
Mosoka Fallah practices practicing medicine in Addis Ababa, Ethiopia. Fallah is rated as an Elite expert by MediFind in the treatment of Ebola Virus Disease. They are also highly rated in 3 other conditions, according to our data. Their clinical expertise encompasses Ebola Virus Disease, Viral Hemorrhagic Fever, COVID-19, and Scabies.
Shihua He practices practicing medicine in Winnipeg, Canada. He is rated as an Elite expert by MediFind in the treatment of Ebola Virus Disease. They are also highly rated in 3 other conditions, according to our data. Their clinical expertise encompasses Ebola Virus Disease, Marburg Hemorrhagic Fever, Viral Hemorrhagic Fever, and Sepsis.
Summary: This study is a vaccine-related clinical trial which will be conducted by our study team at Kenema Government Hospital (KGH)'s Viral Hemorrhagic Fever Program in collaboration with Tulane University School of Medicine. This study is funded by Merck \& Co., the developers of ERVEBO®. This investigational medicinal product (IMP) was successful in Sierra Leone through the Sierra Leone Trial to Introd...
Summary: The goal of this randomized controlled trial is to investigate whether individuals in DRC previously vaccinated with Zabdeno/Mvabea® or Ervebo® vaccine schedules against Ebola virus can be safely and adequately boosted with homologous or heterologous vaccine schedules. Participants will be randomized to receive either a homologous or heterologous vaccine schedule and will be asked to come to the c...